Drugs / Recombinant Hepatitis B vaccine (Registered BioFarma)
Recombinant Hepatitis B vaccine (Registered BioFarma)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05482282 Comparator | Dec 2025 → Dec 2026 | hepatitis B virus infection | PT Bio Farma | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Hepatitis B vaccine (Registered BioFarma) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05482282 ↗ |
| Modality | Vaccine | “Recombinant Hepatitis B vaccine (Registered BioFarma)” NCT05482282 ↗ |